Providing Strategic Medical Guidance in Advancing HyBryte™ Clinical Development PRINCETON, N.J., Oct. 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare...
Hence then, the article about soligenix updates united states medical advisory board for cutaneous t cell lymphoma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma )
Also on site :
- U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combined
- Goldfish Is Offering Fans Free Crackers for Tax Day—Here’s How To Claim Yours
- Cannes: Studiocanal Boards Jeanne Herry’s Palme D’Or Contender ‘Another Day’ & Unveils First Look